Interleukin-1 Receptor Antagonist [EPC]

13022 reported adverse events

Drugs of this class: ANAKINRA

These side effects are most commonly reported by patients taking drugs of the Interleukin-1 Receptor Antagonist [EPC] class:

# Side effect Count
0 OFF LABEL USE 3918
1 DRUG INEFFECTIVE 3500
2 RHEUMATOID ARTHRITIS 1408
3 PAIN 1352
4 CONDITION AGGRAVATED 1172
5 JOINT SWELLING 1109
6 ARTHRALGIA 1052
7 DRUG INTOLERANCE 1008
8 INJECTION SITE PAIN 894
9 PYREXIA 871
See all common reactions for Interleukin-1 Receptor Antagonist [EPC]

Drugs of the Interleukin-1 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 275 0.9136
1 BODY HEIGHT BELOW NORMAL 288 0.4691
2 ANKLE ARTHROPLASTY 78 0.3047
3 SHORT STATURE 32 0.2689
4 INTESTINAL SEPSIS 49 0.2552
5 AUTOINFLAMMATORY DISEASE 32 0.2406
6 JUVENILE IDIOPATHIC ARTHRITIS 317 0.1642
7 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 342 0.1641
8 HEPATOSPLENIC T-CELL LYMPHOMA 48 0.1437
9 ANTIBODY TEST POSITIVE 205 0.1367
See all enriched reactions for Interleukin-1 Receptor Antagonist [EPC]